Among the lung-specific TFs inactivated in lung cancer and precursor lesions, and which may be implicated in early causal pathways, it is worth highlighting the following:the TF FOXJ1 was found to be inactivated in LSCC, LCIS, and marginally so in buccal tissue of smokers (Table 1). Here, FOXJ1 is linked to lung cancer.